The US Food and Drug Administration on Wednesday approved the first drug to treat obesity in 13 years, a drug called lorcaserin, marketed as Belviq and made by Arena Pharmaceuticals.
Related posts:
Rise of the pushy parents: One in three admit to training their children so they perform well on sch...
“The Aliens Are Coming”: Psychological Programmers Versus The Alternative Media
Israeli Man Dies in Eiffel Tower Suicide
New Cybersecurity Proposal: Privacy Vulnerabilities
Facebook's U.S. Growth Is Slowing [REPORT]
Top marine scientists warn reefs in rapid decline